The important benefits of attending this congress includes:
- Improve knowledge of stem cell mobilization strategies for patients with multiple myeloma (MM) and non-Hodgkin lymphoma (NHL) undergoing ASCT
- Gain expert insight into available strategies to increase the efficacy of stem cell mobilization
- Learn from the experts how to manage patients at high risk for poor mobilization
- Individualize stem cell mobilization and mitigate treatment-related toxicities
Benefits of Attending
- Get insights regarding risk assessment in CMV post HSCT
- Hear experts discuss best practices on preventing and treating CMV infections in transplant patients
- Learn about current and evolving treatments that are changing the treatment paradigm
The important benefits of attending this congress includes:
- Understand how to diagnose HSCT-TMA
- Review best practices for managing challenging patient cases
- Learn about current and evolving treatments
The important benefits of attending this congress includes:
- Hear recent updates from clinical studies evaluating CAR T-cell therapy in patients with multiple myeloma (MM)
- Gather expert perspectives on the use of CAR T-cell therapy for the treatment of MM
- Learn strategies to mitigate CAR T–associated adverse events